Jill JF Belch
Has grant
Academic, Clinical Professor (Teaching and Research) of Vascular Medicine
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Dr. Jill JF Belch is a Clinical Professor of Vascular Medicine at the University of Dundee, United Kingdom. Her research primarily focuses on venous thromboembolism, wet macular degeneration, and sex-specific cardiovascular outcomes. Notable recent publications include the 2025 ESVM guidelines on interventional treatment of venous thromboembolism and editorials addressing exercise therapy for chronic symptomatic peripheral artery disease. Dr. Belch is also actively involved in exploring the implications of sex in cardiac operations and the ASSIGN score's relationship with cancer risk.
Recent Grants
Grant: Close
Promoting the detection of vascular risk: SHARP
Open Date: 2020-01-01
Close Date: 2025-01-01
Grant: Close
Cardiovascular Research: From Imaging to Population Health, TICR
Open Date: 2019-01-01
Close Date: 2022-01-01
Grant: Close
SHHEC Research Coalition: a study of novel markers for chronic disease, data linkage with EDRIS
Open Date: 2019-01-01
Close Date: 2022-01-01
Grant: Close
Pollution and Air Quality Management Area (AQMA)
Open Date: 2019-01-01
Close Date: 2021-01-01
Grant: Close
SHHEC Research Coalition: a study of novel markers for cardiovascular disease, Alzheimer’s and cancer, data linkage with EDRIS
Open Date: 2018-01-01
Close Date: 2021-01-01
Articles (20)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Summary: Endovascular interventions and diagnostic examinations using iodinated contrast media (ICM) are standard of care in current vascular medicine. Although ICM use is generally considered safe, it may be associated with adverse reactions, vary from minor disturbances to rare, but severe life-threatening complications. This position paper of European Society of Vascular Medicine integrates current knowledge and summarizes the key information related to the use of intravascular ICM, serving as recommendation on prevention and management of acute, late, and very late adverse reactions. It should help the health professionals in all fields of vascular medicine to make decisions in daily practice for safe use of contrast media.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Collaborators (17)
Marco De Carlo
University of Pisa
Anna Falanga
Full Professor of Hematology
University of Milano-Bicocca
Juraj Madaric
-
Victor Aboyans
-
Faisel Khan
Academic, Professor (Teaching and Research) of Cardiovascular Sciences
University of Dundee
Sam Schulman
Professor
McMaster University
Christian Heiss
Professor of Cardiovascular Medicine, Head of Department
University of Surrey
Daniel Staub
Head of Department
University Hospital Basel
Stefano Lanzi
Lausanne University Hospital
Nasser Malyar
University Hospital
Angela Shore
Professor of Cardiovascular Science
University of Exeter
Konstantinos Kyriakoulis
-
Peter Marschang
Medical University of Innsbruck
Chris Seenan
Senior Lecturer
Glasgow Caledonian University
Maarit Venermo
University of Helsinki
Francesco Casanova
University of Exeter Medical School
MARIA CATALANO
University of Milan
Make your next move.
Prepare your application
Review drafts before you send them.